One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Sorafenib toluenesulfonate is a synthetic compound of sorafenib that targets growth signals and angiogenesis. Sorafenib blocks the enzyme RAF kinase, which is a key component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; In addition, sorafenib inhibits VEGFR-2/PDGFR- β Signal cascade, thereby blocking tumor angiogenesis.
One year of qualification
Audited Supplier
Pharma Sources Insight January 2025
